Prevalence of Sexual Dysfunction among Postmenopausal Women with and without Metabolic Syndrome

Journal of Sexual Medicine

Volumn 9, Issue 2, 2012, Pages 434-441

  Martelli, Valentina ^a   Valisella, Sara ^a   Moscatiello, Simona ^a   Matteucci, Carlotta ^a   Lantadilla, Claudia ^a   Costantino, Antonietta ^a   Pelusi, Giuseppe ^b   Marchesini, Giulio ^a   Meriggiola, Maria Cristina ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Blood pressure; FSD; FSFI; Metabolic syndrome; Sexual dysfunction; Tryglicerides

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; AROUSAL; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE SEXUAL DISTRESS SCALE; FEMALE SEXUAL DYSFUNCTION; FEMALE SEXUAL FUNCTION INDEX QUESTIONNAIRE; HEALTH PROGRAM; HUMAN; LUBRICATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MIDDLESEX HOSPITAL QUESTIONNAIRE; ORGASM; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALITY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84856515515     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02517.x     Document Type: Article

References (57)

1. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: A survey of western European women. J Sex Med 2006;3:212-22.
2. Genazzani AR, Gambacciani M, Simoncini T. Menopause and aging, quality of life and sexuality. Climacteric 2007;10:88-96.
3. Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: Focus of findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007;13:559-65.
4. Panzer C, Guay A. Testosterone replacement therapy in naturally and surgically menopausal women. J Sex Med 2009;6:8-18; quiz 19-20.
5. Lara LA, Useche B, Ferriani RA, Reis RM, De Sá MF, De Freitas MM, Rosa e Silva JC, Rosa e Silva AC. The effects of hypoestrogenism on the vaginal wall: Interference with the normal sexual response. J Sex Med 2009;6:30-9.
6. Berra M, De Musso F, Matteucci C, Martelli V, Perrone AM, Pelusi C, Pelusi G, Meriggiola MC. The impairment of sexual function is less distressing for menopausal than for pre-menopausal women. J Sex Med 2010;7:1209-15.
7. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:427-36.
8. Berg G, Mesch V, Boero L, Sayegh F, Prada M, Royer M, Muzzio ML, Schreier L, Siseles N, Benencia H. Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution. Horm Metab Res 2004;36:215-20.
9. Ferrara CM, Lynch N, Nicklas B, Ryan S, Berman D. Differences in adipose tissue metabolism between post-menopausal and peri-menopausal women. J Clin Endocrinol Metab 2002;87:4166-70.
10. Park YW, Zhu S, Palaniappa L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:D356-9.
12. Balkau B. Epidemiology of the metabolic syndrome and the RISC study. Eur Heart J Suppl 2005;7:D6-D9.
13. Miccoli R, Bianchi C, Odoguardi L, Penno G, Caricato F, Giovannitti MG, Pucci L, Del Prato S. Prevalence of metabolic syndrome among Italian adults according to ATP III definition. Nut Metab Cardiovasc Dis 2005;15:250-4.
14. Esposito K, Ciotola M, Maiorino IM, Giuliano F, Autorino R, De Sio M, Cozzolino D, Saccomanno F, Giugliano D. Hyperlipidemia and sexual function in pre-menopausal women. J Sex Med 2009;6:1696-703.
15. Esposito K, Ciotola M, Martella R, Di Tommaso D, Cobellis L, Giugliano D. The metabolic syndrome: A cause of sexual dysfunction in women. Int J Impot Res 2005;17:224-6.
16. Ponholzer A, Temml C, Rauchenwald M, Marszalek M, Madersbacher S. Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? Int J Impot Res 2008;20:100-4.
17. Kirchengast S, Hartmann B, Gruber D, Huber J. Decreased sexual interest and its relationship to body build in post-menopausal women. Maturitas 1996;23:63-71.
18. Alberti KGGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James PT, Loria M, Smith SC Jr. Harmonizing the metabolic syndrome. A point interim statement of the International Diabetes Federation task force on the Epidemiology and Prevention; National Heart, Lung and Blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
19. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of reproductive aging workshop (STRAW). Climateric 2001;4:267-72.
20. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multi-dimensional self-assessment tool for the evaluation of female sexual function. J Sex Marital Ther 2000;26:191-208.
21. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 2003;29:39-46.
22. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): Cross-validation and development of clinical cut-off scores. J Sex Marital Ther 2005;31:1-20.
23. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28:317-30.
24. Ter Kuile MM, Brauer M, Laan E. The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS): Psychometric properties within a Dutch population. J Sex Marital Ther 2006;32:289-304.
25. Meston CM, Derogatis LM. Validated instruments for assessing female sexual function. J Sex Marital Ther 2002;28:155-64.
26. Crown S, Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (MHQ). Br J Psychiatry 1966;112:917-23.
27. Dioguardi N, Comazzi AM, Nielsen MP. Psychological of the spa user. Preliminary study of motivation for spa treatment. Minerva Med 1984;75:2793-8.
28. Meriggiola MC, Bremner WJ, Paulsen CA, Valdiserri A, Incorvaia L, Motta R, Pavani A, Capelli M, Flamigni C. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. J Clin Endocrinol Metab 1996;81:3018-23.
29. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44.
30. Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the "true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med 2008;5:777-87.
31. Murray W. Decreased libido in post-menopausal women. Nurse Pract Forum 2000;11:219-24.
32. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E, Leiblum S, Padma-Nathan H, Rosen R, Segraves K, Segraves RT, Shabsigh R, Sipski M, Wagner G, Whipple B. Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications. J Urol 2000;163:888-93.
33. Nappi RE, Albani F, Vaccaio P, Gardella B, Salonia A, Chiamato L, Spinillo A, Pollati F. Use the Italian translation of the Female Sexual function Index (FSFI) in routine gynecological practice. Gynecol Endocrinol 2008;24:214-9.
34. Montorsi F, Briganti A, Salonia A, Rigatti P, Marginato A, Macchi A, Galli S, Ravagnani PM, Montorsi P. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44:360-4.
35. Corona G, Forti G, Maggi M. Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome. Aging Male 2008;11:193-9.
36. Doumas M, Tsiodras S, Tsakiris A, Douma S, Chounta A, Papadopoulos A, Kanellakopoulou K, Giamarellou H. Female sexual dysfunction in essential hypertension: A common problem being uncovered. J Hypertens 2006;24:2387-92.
37. Gragasin FS, Michelakis ED, Hogan A, Moudgil R, Hashimoto K, Wu X, Bonnet S, Haromy A, Archer SL. The neurovascular mechanism of clitoral erection: Nitric Oxide and cGMP- stimulated activation of BKCa channels. Faseb J 2004;18:1382-91.
38. Kim SW, Jeong SJ, Munarriz R, Kim NN, Goldstein I, Traish AM. Role of the nitric oxide-cyclic GMP pathway in regulation of vaginal blood flow. Int J Impot Res 2003;15:355-61.
39. Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, Azadzoi KM. Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 1997;9:27-37.
40. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: Vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res 1998;10:84-90.
41. Tyer G, Steel JM, Ewing DJ, Bancroft J, Warner P, Clarke BF. Sexual responsiveness in diabetic women. Diabetologia 1983;24:166-71.
42. Schreiner-Engel P, Schiavi RC, Vietorisz D, Smith H. The differential impact of diabetes type on female sexuality. J Psychosom Res 1987;31:23-33.
43. Meeking DR, Fosbury JA, Cracdock S. Assessing the impact of diabetes on female sexuality. Community Nurse 1997;3:50-2.
44. Enzlin P, Mathieu C, Van den Bruel A, Vanderschueren D, Demyttenaere K. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care 2003;26:409-14.
45. Rutherford D, Collier A. Sexual dysfunction in women with diabetes mellitus. Gynecol Endocrinol 2005;21:189-92.
46. Mezones-Holguin E, Blumel JE, Huezo M, Vargas R, Castro J, Cordova W, Valenzuela G, Castelo-Branco C. Impact of diabetes mellitus on the sexuality of Peruvian post-menopausal. Gynecol Endocrinol 2008;24:470-4.
47. Giraldi A, Kristensen E. Sexual dysfunction in women with diabetes mellitus. J Sex Res 2010;47:199-211.
48. Esposito K, Maiorino MI, Bellastella G, Giugliano F, Romano M, Giugliano D. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res 2010;22:179-84.
49. Kutmec C, Yurtserver S. Effects of sexual function of essential hypertensions in women. Eur J Cardiovasc Nurs 2011;10:56-63.
50. Duncan LE, Lewis C, Jenkins P, Pearson TA. Does hypertension and its pharmacolotherapy affect the quality of sexual function in women? Am J Hypertens 2000;13:640-7.
51. Okeahialam BN, Obeka NC. Sexual dysfunction in female hypertensives. J Natl Med Assoc 2006;98:638-64.
52. Kadioglu P, Yetkin DO, Sanli O, Yalin AS, Onem K, Kadioglu A. Obesity might not be a risk factor for female sexual dysfunction. BJU Int 2010;106:1357-61.
53. Esposito K, Giugliano D. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 2005;17:391-8.
54. Kaneshiro B, Jensey JT, Carlson NE, Harvey SM, Nichols MD, Edelman AB. Body mass index and sexual behaviour. Obstet Gynecol 2008;112:586-92.
55. Yayli GF, Tekekoglu S, Akin F. Sexual dysfunction in obese and overweight women. Int J Impot Res 2010;22:220-6.
56. Esposito K, Ciotola M, Giugliano F, Bisogni C, Schisano B, Autorino R, Cobellis L, De Sio M, Colacurci N, Giugliano D. Association of body weight with sexual function. Int J Impot Res 2007;19:353-7.
57. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and stress in American women. Obstet Gynecol 2008;112:970-8.